Creative Planning

Position in PCVX — Vaxcyte, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in PCVX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,020,417

-$1,125,268 QoQ

Shares Held

120,771

-13.8% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#95

of 329 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. PCVX ranks #19 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,020,417	120,771	-13.8%	Shares	Defined	2026-08-13
2026-03-31	$8,145,685	140,177	+36.5%	Shares	Defined	2026-05-12
2025-12-31	$4,737,932	102,686	+27.8%	Shares	Sole	2026-02-17
2025-09-30	$2,893,234	80,323	+2.4%	Shares	Sole	2025-11-14
2025-06-30	$2,551,058	78,470	+101.3%	Shares	Sole	2025-08-08
2025-03-31	$1,471,847	38,979	-16.7%	Shares	Sole	2025-05-15
2024-12-31	$3,832,766	46,821	+24.8%	Shares	Defined	2025-02-14
2024-09-30	$4,287,981	37,525	+37.6%	Shares	Defined	2024-10-11
2024-06-30	$2,059,910	27,280	+64.0%	Shares	Defined	2024-08-15
2024-03-31	$1,136,541	16,638	+39.2%	Shares	Defined	2024-05-13
2023-12-31	$750,459	11,950	+31.7%	Shares	Defined	2024-02-14
2023-09-30	$462,642	9,075	+40.9%	Shares	Sole	2023-11-16
2023-06-30	$321,662	6,441	+50.9%	Shares	Defined	2023-07-21
2022-12-31	$204,698	4,269	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.